Affymax Inc., of Palo Alto, Calif., named Karin L. Walker vice president of finance and chief accounting officer...Theratechnologies Inc., of Montreal, appointed Luc Tanguay interim president and CEO...Zyngenia Inc., of Gaithersburg, Md., added Christian Itin and Jason Rhodes to its board

BioMotiv LLC, of Cleveland, named Baiju R. Shah CEO and board member, effective Sept...GenSpera Inc., of San Antonio, named Nancy Jean Barnabei vice president of finance and treasurer

he will chair the audit committee and serve on the compensation committee...Pharmacyclics Inc., of Sunnyvale, Calif., appointed Joshua Brumm executive vice president of finance

Agensys Inc., of Santa Monica, Calif., a subsidiary of Astellas Inc., appointed Frank P. Hudson vice president of finance and named Wolfgang Noe vice president of process sciences and manufacturing...BioTime Inc., of Alameda, Calif., and its subsidiary, OncoCyte Corp., each appointed Andrew von Eschenbach to their boards

and Alan W. Dunton as consulting chief medical officer...Medivir AB, of Huddinge, Sweden, made several recent appointments, including Maris Hartmanis as deputy CEO and chief operating officer...and Jens D. Kristensen as executive vice president of clinical

Affimed Therapeutics AG, of Heidelberg, Germany, named Adi Hoess CEO and appointed Rolf Guenther chief operating officer...and Alexander H. Burgess as vice president of marketing...CardioDx, of Palo Alto, Calif., named Andrew L. Guggenhime chief financial officer and appointed Mark Monane chief medical officer

Tim Henkel as executive vice president and head of R&D...Doug Gessl as chief operating officer and chief financial officer...and Lisa Wittmer as vice president of regulatory affairs

The firm also nominated Stuart Strathdee and Ganesh Kishore to its board...Medivation Inc., of San Francisco, appointed Gretchen Burke vice president of finance and business processes

Cumberland Pharmaceuticals Inc., of Nashville, Tenn., appointed Rick S. Greene interim vice president of finance and accounting...Lightlake Therapeutics Inc., of London, appointed Cynthia McCormick as senior clinical and regulatory advisor

Affymax Inc., of Palo Alto, Calif., named Herb Cross vice president of finance and chief accounting officer...Cornerstone Therapeutics Inc., of Cary, N.C., appointed Vincent Morgus executive vice president of finance and chief financial officer...Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...PDL BioPharma Inc., of Incline Village, Nev., appointed Caroline Krumel vice president of finance and chief accounting officer

Markus Leyck Dieken senior vice president and general manager, Germany...and Manuela Maronati vice president, sales and marketing, Europe

Affymax Inc., of Palo Alto, Calif., appointed Herb Cross chief accounting officer and vice president of finance

to chief operating officer and David R. Holland to senior vice president of sales and marketing...It also added William T. Pappafotopoulos as vice president of finance and administration

Adeona Pharmaceuticals Inc., of Ann Arbor, Mich., appointed Julie A. Caudill vice president of finance and corporate controller...Ambit Biosciences Corp., of San Diego, appointed Alan J. Lewis chairman and CEO...Lewis, who most recently served as president and CEO of the Juvenile Diabetes Research Foundation, has been serving as Ambit's executive chairman since March

Cerulean Pharma Inc., of Cambridge, Mass., appointed John Ryan senior vice president and chief medical officer and named Karen Roberts senior vice president of finance and administration

Tom Amick will serve as president and CEO, while Edward L. Field was named executive vice president and chief business officer...Alexza Pharmaceuticals Inc., of Mountain View, Calif., promoted Mark K. Oki to vice president of finance and controller

team, with Greg Hamilton as chief operating officer and chief financial officer...Suzanne McDonald head of managed markets and government affairs...operations and also appointed Jon Terrett vice president of oncology at its San Jose, Calif

BioAlliance Pharma SA, of Paris, appointed André Ulmann and Denis Biju-Duval to its supervisory board...BrainCells Inc., of San Diego, appointed Edward Scolnick and David Holtzman to its scientific advisory board...DBV Technologies, of Paris, added Gideon Lack and Philippe Eigenmann to its scientific advisory board